Literature DB >> 29031418

Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: A report from the National Cancer Database.

Kyrollis Attalla1, David J Paulucci2, Kyle Blum2, Harry Anastos2, Kelvin A Moses3, Ketan K Badani2, Philippe E Spiess4, John P Sfakianos2.   

Abstract

OBJECTIVES: To evaluate whether socioeconomic factors affect pathologic stage, treatment delays, pathologic upstaging, and overall survival (OS) in patients with penile cancer (PC). PATIENTS AND METHODS: A total of 13,283 eligible patients diagnosed with PC from 1998 to 2012 were identified from the National Cancer Database. Socioeconomic, demographic and pathologic variables were used in multivariable regression models to identify predictors of pathologic T stage ≥2, pathologic lymph node positivity, cT to pT upstaging, treatment delays, and OS.
RESULTS: A 5-year OS was 61.5% with a median follow-up of 41.7 months. Pathologic T stage ≥2 was identified in 3,521 patients (27.2%), 1,173 (9.2%) had ≥pN1 and 388 (7.9%) experienced cT to pT upstaging. Variables associated with a higher likelihood of pathologic T stage ≥2 included no insurance (OR = 1.79, P<0.001), lower higher education based on zip code (OR = 1.13, P = 0.027), black race (OR = 1.17, P = 0.046) and Hispanic ethnicity (OR = 1.66, P<0.001). Patients with Hispanic ethnicity (OR = 1.46; P<0.001) or living in nonmetropolitan areas were more likely to have ≥pN1 (P = 0.001). Lack of insurance was associated with cT to pT upstaging (OR = 2.05, P = 0.001) as was living in an urban vs. metropolitan area (OR = 1.35, P = 0.031). In addition to TNM stage, black vs. white race (HR = 1.56, P<0.001), living in an urban vs. metropolitan area (hazard ratio [HR] = 1.18, P = 0.022), age (HR = 1.04, P<0.001) and Charlson score (HR = 1.49, P<0.001) were associated with lower OS.
CONCLUSION: Socioeconomic variables including no insurance, lower education, race, Hispanic ethnicity, and nonmetropolitan residence were found to be poor prognostic factors. Increased educational awareness of this rare disease may help reduce delays in diagnosis, improve prognosis and ultimately prevent deaths among socioeconomically disadvantaged men with PC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disparities; National Cancer Database; Overall survival; Penile cancer; Socioeconomic status

Mesh:

Year:  2017        PMID: 29031418     DOI: 10.1016/j.urolonc.2017.09.014

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  8 in total

1.  Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis.

Authors:  Maria T Bourlon; Haydee Verduzco-Aguirre; Elizabeth Molina; Elisabeth Meyer; Elizabeth Kessler; Simon P Kim; Philippe E Spiess; Thomas Flaig
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

2.  Trends in Incidence, Mortality, and Survival of Penile Cancer in the United States: A Population-Based Study.

Authors:  Xinxi Deng; Yang Liu; Xiangpeng Zhan; Tao Chen; Ming Jiang; Xinhao Jiang; Luyao Chen; Bin Fu
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

3.  The Diagnosis and Treatment of Penile Cancer.

Authors:  Oliver Walther Hakenberg; Desiree Louise Dräger; Andreas Erbersdobler; Carsten Maik Naumann; Klaus-Peter Jünemann; Chris Protzel
Journal:  Dtsch Arztebl Int       Date:  2018-09-28       Impact factor: 5.594

4.  Underutilization of Surgical Standard of Care for Insured Men with Invasive Penile Cancer.

Authors:  Edward K Chang; Rishi R Sekar; Sarah K Holt; John L Gore; Jonathan L Wright; Yaw A Nyame
Journal:  Urol Pract       Date:  2021-05-01

Review 5.  A global approach to improving penile cancer care.

Authors:  Marco Bandini; Mohamed Ahmed; Giuseppe Basile; Nicholas Watkin; Viraj Master; Yao Zhu; Gagan Prakash; Alejandro Rodriguez; Mbaaga K Ssebakumba; Riccardo Leni; Giuseppe Ottone Cirulli; Ben Ayres; Rachel Compitello; Filippo Pederzoli; Pankaj M Joshi; Sanjay B Kulkarni; Francesco Montorsi; Guru Sonpavde; Andrea Necchi; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2021-12-22       Impact factor: 16.430

6.  A comprehensive analysis of penile cancer in the region with the highest worldwide incidence reveals new insights into the disease.

Authors:  Antonio Augusto Lima Teixeira Júnior; Syomara Pereira da Costa Melo; Jaqueline Diniz Pinho; Thaís Bastos Moraes Sobrinho; Thalita Moura Silva Rocha; Denner Rodrigo Diniz Duarte; Liseana de Oliveira Barbosa; Wesliany Everton Duarte; Marta Regina de Castro Belfort; Kelly Gomes Duarte; Antonio Lima da Silva Neto; José de Ribamar Rodrigues Calixto; Lúcio Cristiano Paiva Paiva; Francisco Sérgio Moura Silva do Nascimento; Antonio Machado Alencar Junior; André Salim Khayat; Rita da Graça Carvalhal Frazão Corrêa; Joyce Santos Lages; Rodolfo Borges Dos Reis; Wilson Silva Araújo; Gyl Eanes Barros Silva
Journal:  BMC Cancer       Date:  2022-10-15       Impact factor: 4.638

7.  Novel Prognostic Models for Patients With Penile Carcinoma.

Authors:  Monica E Reyes; Heloise Borges; Muhamed Said Adjao; Nisha Vijayakumar; Philippe E Spiess; Matthew B Schabath
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

8.  Education level as a predictor of survival in patients with multiple myeloma.

Authors:  Limei Xu; Xiuju Wang; Xueyi Pan; Xiaotao Wang; Qing Wang; Bingyi Wu; Jiahui Cai; Ying Zhao; Lijuan Chen; Wuping Li; Juan Li
Journal:  BMC Cancer       Date:  2020-08-08       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.